Momenta Pharmaceuticals, Inc. (MNTA)

[kris_kade]

Exactly !! And some Motley Fool (and you wonder why they call themselves fools) will post some rubbish without doing any homework...see below..I bet some of the downdraft on the price today was due to this article..

"Sounds cheap, no? There's just one problem. Those earnings are based solely on the fact that there aren't any other generic competitors, which allows Novartis to price the drug at close to the price of branded Lovenox. If the Food and Drug Administration approves a pending application from Teva Pharmaceutical (Nasdaq: TEVA) and another from Amphastar Pharmaceuticals, which is partnered with Watson Pharmaceuticals (NYSE: WPI), Novartis will have to drop the price, and Momenta's share changes from a profit share to a royalty.

Without any indication of when or if those applications will be approved, investors don't have much other choice than to price in the possibility that Momenta's momentum will be stopped and enjoy the insane profits while they last."